Researcher
Piet STINISSEN
- Keywords:Biomedical sciences (incl. biochemistry)
- Disciplines:Autoimmunity, Inflammation, Genetics, Neurological and neuromuscular diseases
Affiliations
- Limburg Clinical Research Center (Research Center)
Responsible
From1 Sep 2022 → Today - Immunology & Infection (Department)
Member
From1 Jan 2020 → Today - Immunology & Infection (Research group)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Member
From1 Jan 2020 → Today - Limburg Clinical Research Center (Research Center)
Responsible
From1 Jan 2020 → Today - Biomedical Research Institute (Research institute)
Member
From1 Oct 2005 → Today - Faculty of Medicine and Life Sciences (Faculty)
Member
From1 Jan 1999 → Today - Biomedical Research Institute (Research institute)
Responsible
From1 Oct 2005 → 10 Nov 2009 - Physiology - Biochemistry - Immunology (Department)
Member
From1 Oct 2003 → 31 Dec 2019 - Medical Basic Sciences (Division)
Member
From1 Jan 1999 → 30 Sep 2009 - Immunology - Biochemistry (Research group)
Member
From1 Jan 1992 → 31 Dec 2019 - Immunology - Biochemistry (Research group)
Responsible
From1 Jan 1992 → 31 Dec 2019
Projects
51 - 60 of 62
- Validation of advanced, macrophage-targeted vaccines for MSFrom1 Jan 2010 → 31 Dec 2012Funding: IOF - Industrial Research Fund
- Study of the role of new candidate autoantigens in Multiple SclerosisFrom1 Jan 2010 → 31 Dec 2013Funding: Foundations, funds and other with scientific goal
- Expansion Research on patient safety UHasselt: Patient Safety Plan 2.0From3 Feb 2009 → 31 Dec 2017Funding: BOF - Doctoral projects
- Clinical and preclinical research of the effect of cellular mediators on the modulation of pathogenic responses in multiple sclerosisFrom1 Jan 2009 → 31 Dec 2012Funding: FWO fellowships
- LifeTechLimburg@workFrom15 Dec 2008 → 14 Dec 2010Funding: Other EU initiatives out of framework
- BOF 2008 - BONUS: Mandate Bart TessensFrom1 Oct 2008 → 30 Sep 2009Funding: BOF - Other initiatives
- Validation of new molecular markers for MS.From1 Sep 2008 → 31 Aug 2009Funding: IOF - Industrial Research Fund
- SKILLS3: Creating a Euregional Labour Market in Life ScienceFrom1 Jul 2008 → 30 Jun 2011Funding: Provinces, Ministery of Economical Affairs, Other EU initiatives out of framework, Own budget, for example: patrimony, inscription fees, gifts
- EFRO-project 1.2.52/02/1202 "Purchase of scientific research equipment: 'Transcranial Magnetic Stimulation (TMS)" in the context of the Objective 2-program 2000-2006 - BIOMED, RevalFrom24 Jun 2008 → 30 Jun 2009Funding: Other EU initiatives out of framework, Own budget, for example: patrimony, inscription fees, gifts
- EFRO-project 1.2.48./D2/1208 "Extension scientific equipment" in the context of the Objective 2-program 2000-2006 - BIOMEDFrom23 Jun 2008 → 30 Jun 2009Funding: Other EU initiatives out of framework, Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 158
- Fatty acid desaturation by stearoyl-CoA desaturase-1 controls regulatory T cell differentiation and autoimmunity(2023)
Authors: Elien GRAJCHEN, Melanie LOIX, Paulien BAETEN, Beatriz FERNANDES CORTE-REAL, Ibrahim HAMAD, Sam VANHERLE, Mansour HAIDAR, Jonas Dehairs, Jelle Y. Broos, James M. Ntambi, et al.
Pages: 666 - 679 - Differential Runx3, Eomes, and T-bet expression subdivides cytotoxic CD4+memory T cells with brain-homing capacity(2023)
Authors: Cindy HOEKS, Fabienne van Puijfelik, Steven Koetzier, Jasper Rip, Cato Corsten, Annet Wierenga-Wolf, Marie-Jose Melief, Piet STINISSEN, Joost Smolders, Niels HELLINGS, et al.
Pages: 232 - Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort(2023)
Authors: Pieter RUYTINX, Patrick VANDORMAEL, Judith FRAUSSEN, Zoe PIETERS, Stef Thonissen, Niels HELLINGS, Piet STINISSEN, Ina CALLEBAUT, Joris PENDERS, Karolien VANHOVE, et al.
- Treg-Resistant Cytotoxic CD4+ T Cells Dictate T Helper Cells in Their Vicinity: TH17 Skewing and Modulation of Proliferation(2021)
Authors: Cindy HOEKS, Marjan VANHEUSDEN, Liesbet PEETERS, Piet STINISSEN, Bieke BROUX, Niels HELLINGS
- Multiple Sclerosis Data Alliance - A global multi-stakeholder collaboration to scale-up real world data research(2021)
Authors: Liesbet PEETERS, Tina PARCIAK, Dipak Kalra, Yves Moreau, Elisabeth Kasilingam, Pieter van Galen, Christoph Thalheim, Bernard Uitdehaag, Patrick Vermersch, Niels HELLINGS, et al.
- Liver X receptor beta deficiency attenuates autoimmune-associated neuroinflammation in a T cell-dependent manner(2021)
Authors: Jeroen BOGIE, Tim VANMIERLO, Jasmine VANMOL, Silke TIMMERMANS, Jo MAILLEUX, Erwin Wijnands, Katherine NELISSEN, Jan-Ake Gustafsson, Piet STINISSEN, Kristiaan WOUTERS, et al.
- CNS delivery of anti-CD52 antibodies modestly reduces disease severity in an animal model for multiple sclerosis(2020)
Authors: Jeroen BOGIE, Elien GRAJCHEN, Elien WOUTERS, Bieke BROUX, Piet STINISSEN, Bart VAN WIJMEERSCH, Jerome HENDRIKS
- Altered PPARγ Expression Promotes Myelin-Induced Foam Cell Formation in Macrophages in Multiple Sclerosis(2020)
Authors: Elien WOUTERS, Elien GRAJCHEN, Winde JORISSEN, Tess DIERCKX, Suzan WETZELS, Melanie LOIX, Marie-Paule TULLENERS, Bart Staels, Piet STINISSEN, Mansour HAIDAR, et al.
- Raising to the Challenge: Building a Federated Biobank to Accelerate Translational Research—The University Biobank Limburg(2019)
Authors: Loes LINSEN, Kimberly VANHEES, Evi VANOPPEN, Kim ULENAERS, Suzanne Driessens, Joris PENDERS, Veerle SOMERS, Piet STINISSEN, Jean-Luc RUMMENS
- Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells(2018)
Authors: Raf DONDERS, Jeroen BOGIE, Stelios RAVANIDIS, Pascal GERVOIS, Marjan VANHEUSDEN, Raphaël Marée, Marie Schrynemackers, Hubert J.M. Smeets, Jef Pinxteren, Kristel Gijbels, et al.
Pages: 65 - 84
Patents
1 - 9 of 9
- Biomarkers for rheumatoid arthritis (Inventor)
- MEANS AND METHODS FOR THE DETERMINATION OF THE JOINT DESTRUCTION PROGRESSION RATE IN RHEUMATOID ARTHRITIS PATIENTS (Inventor)
- BIOMARKERS FOR MULTIPLE SCLEROSIS (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- METABOLIC MARKERS FOR DIAGNOSING OF CANCER (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- CITRULLINATION SPECIFIC PHAGE DISPLAY (Inventor)
- Biomarkers for rheumatoid arthritis (Inventor)
- BIOMARKERS FOR RHEUMATOID ARTHRITIS (Inventor)